USP1-IN-10 (compound 2) is a potent tricyclic USP1 inhibitor with an IC 50 of 7.6 nM. USP1-IN-10 inhibits MDA-MB-436 viability (IC 50 =21.58 nM). USP1-IN-10 has the potential for cancers research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Deubiquitinase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.